Impact of serum erythropoietin level on collateral vessel development in patients with coronary artery disease

Creative Commons License

ÖZYÜNCÜ N., GÜLEÇ H. S., ÖZDÖL Ç., CANDEMİR B., ONGUN A., TULUNAY KAYA C., ...Daha Fazla

ANATOLIAN JOURNAL OF CARDIOLOGY, cilt.17, sa.5, ss.386-391, 2017 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 17 Sayı: 5
  • Basım Tarihi: 2017
  • Doi Numarası: 10.14744/anatoljcardiol.2017.7419
  • Dergi Adı: ANATOLIAN JOURNAL OF CARDIOLOGY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, TR DİZİN (ULAKBİM)
  • Sayfa Sayıları: ss.386-391
  • Anahtar Kelimeler: coronary collateral, erythropoietin, anemia, ELEVATION MYOCARDIAL-INFARCTION, ISCHEMIA-REPERFUSION INJURY, ENDOTHELIAL PROGENITOR-CELL, NITRIC-OXIDE, BLOOD-FLOW, OCCLUSION, NEOVASCULARIZATION, INTERVENTION, DETERMINANTS, ANGIOGENESIS
  • Ankara Üniversitesi Adresli: Evet

Özet

Objective: Experimental data have shown that Erythropoietin (EPO) stimulates angiogenesis and neovascularization which may result in improved collateral development. The aim of this study was to investigate the association between serum EPO levels and the extent of coronary collaterals. Patient characteristics possibly related with coronary collaterals were also sought.